Structure | Compound Name | Standard Type | Standard Values (in nM) |
|---|---|---|---|
| N-[[5-[1-(2-Imidazol-1-ylethyl)indazol-3-yl]-1,2,4-oxadiazol-3-yl]methyl]benzamide | IC50 | 24000.0 [1], 100000.0 [2] | |
| N-[[5-[2-(2-Imidazol-1-ylethyl)indazol-3-yl]-1,2,4-oxadiazol-3-yl]methyl]-3-(trifluoromethoxy)benzamide | IC50 | 3320.0 [1], 32200.0 [2], 100000.0 [3] | |
| 2,2-Diphenyl-N-[4-(1,3-thiazol-2-ylsulfamoyl)phenyl]acetamide | IC50 | 10000.0 [1], 10300.0 [2] | |
| Tetrodotoxin | IC50 | 30.0 [1] | |
| Tetracaine | IC50 | 520.0 [1] | |
MLA | "Quest Database™ Sodium channel protein type VIII alpha subunit Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 15 Dec. 2025, https://www.aatbio.com/data-sets/sodium-channel-protein-type-viii-alpha-subunit-inhibitors-ic50-ki. | |
APA | AAT Bioquest, Inc. (2025, December 15). Quest Database™ Sodium channel protein type VIII alpha subunit Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/sodium-channel-protein-type-viii-alpha-subunit-inhibitors-ic50-ki. | |
| BibTeX | EndNote | RefMan |